Showing results (1701-1710 of 1,783) with videos related to
Sort By:
Pageof 179
Cancer Biology & Therapy|February 13, 2010
Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor typesPaula J Kaplan-Lefko, Jonathan D Graves, Stephen J Zoog, et al.Annals of Internal Medicine|July 4, 2012
Red blood cell transfusion: a clinical practice guideline from the AABB*Jeffrey L Carson, Brenda J Grossman, Steven Kleinman, et al.The Prostate|October 3, 2006
Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer modelSharon D Morgenbesser, Rajashree P McLaren, Brenda Richards, et al.Science Translational Medicine|September 6, 2019
Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativaAngel S Byrd, Carmelo Carmona-Rivera, Liam J O'Neil, et al.Critical Care Explorations|February 2, 2024
Providing Remote Aid During a Humanitarian CrisisLewis J Kaplan, Scott Levin, Jay Yelon, et al.Cell Genomics|March 19, 2026
Functional chromatin signatures premark future lineage-specific enhancersJulian Pulecio, Zakieh Tayyebi, Dingyu Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|June 17, 2020
Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritisChenzhi Jing, Tomas Castro-Dopico, Nathan Richoz, et al.Frontiers in Immunology|January 22, 2019
Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid ArthritisKaty A Lloyd, Gustaf Wigerblad, Peter Sahlström, et al.Cell Reports. Medicine|July 30, 2026
Köhlmeier-Degos disease is an interferonopathy characterized by type I and II interferon-driven inflammatory vasculopathyCornelia D Cudrici, Shubham Goel, Keiko Sakamoto, et al.Pageof 179